BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16575786)

  • 41. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The breakdown of apoptotic mechanism in the development and progression of colorectal carcinoma.
    Ogawa S; Nagao M; Kanehiro H; Hisanaga M; Ko S; Ikeda N; Nakajima Y
    Anticancer Res; 2004; 24(3a):1569-79. PubMed ID: 15274324
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DAP-kinase--protector or enemy in apoptotic cell death.
    Schneider-Stock R; Roessner A; Ullrich O
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1763-7. PubMed ID: 16009322
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promoter methylation of death-associated protein kinase and its role in irradiation response in cervical cancer.
    Leung RC; Liu SS; Chan KY; Tam KF; Chan KL; Wong LC; Ngan HY
    Oncol Rep; 2008 May; 19(5):1339-45. PubMed ID: 18425396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loss of fragile histidine triad gene expression in advanced lung cancer is consequent to allelic loss at 3p14 locus and promoter methylation.
    Wali A; Srinivasan R; Shabnam MS; Majumdar S; Joshi K; Behera D
    Mol Cancer Res; 2006 Feb; 4(2):93-9. PubMed ID: 16513840
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
    Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
    Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
    [TBL] [Abstract][Full Text] [Related]  

  • 47. FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas.
    Mann B; Gratchev A; Böhm C; Hanski ML; Foss HD; Demel G; Trojanek B; Schmidt-Wolf I; Stein H; Riecken EO; Buhr HJ; Hanski C
    Br J Cancer; 1999 Mar; 79(7-8):1262-9. PubMed ID: 10098769
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.
    Song Y; Zhang C
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):605-13. PubMed ID: 18521605
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
    Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
    J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
    Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
    J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between expression and methylation status of p16INK4a and the proliferative activity of different areas' tumour cells in human colorectal cancer.
    Jie G; Zhixiang S; Lei S; Hesheng L; Xiaojun T
    Int J Clin Pract; 2007 Sep; 61(9):1523-9. PubMed ID: 17537196
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary apoptosis of spiral ganglion cells induced by aminoglycoside: Fas-Fas ligand signaling pathway.
    Bae WY; Kim LS; Hur DY; Jeong SW; Kim JR
    Laryngoscope; 2008 Sep; 118(9):1659-68. PubMed ID: 18758324
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
    Tanaka T; Bai T; Yukawa K; Umesaki N
    Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A functional genetic screen identifies regions at the C-terminal tail and death-domain of death-associated protein kinase that are critical for its proapoptotic activity.
    Raveh T; Berissi H; Eisenstein M; Spivak T; Kimchi A
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1572-7. PubMed ID: 10677501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Promoter methylation and down-regulation of DAPK is associated with gastric atrophy.
    Kim WS; Son HJ; Park JO; Song SY; Park C
    Int J Mol Med; 2003 Dec; 12(6):827-30. PubMed ID: 14612952
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in loss of p16INK4 protein expression by promoter methylation between left- and right-sided primary colorectal carcinomas.
    Schneider-Stock R; Boltze C; Peters B; Höpfner T; Meyer F; Lippert H; Roessner A
    Int J Oncol; 2003 Oct; 23(4):1009-13. PubMed ID: 12963980
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CD95 ligand expression in dedifferentiated breast cancer.
    Müschen M; Moers C; Warskulat U; Niederacher D; Betz B; Even J; Lim A; Josien R; Beckmann MW; Häussinger D
    J Pathol; 1999 Nov; 189(3):378-86. PubMed ID: 10547600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.